Oncology Medical News about malignant glioma

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. Recommendations on the use of 18F-FDG PET in oncology

3. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials

4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer

5. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Role of a second chemotherapy in recurrent malignant glioma patients who progress on bevacizumab
Neuro-Oncology, 10/06/09

Quant EC et al. – Those patients with malignant gliomas who progressed despite a bevacizumab–containing regimen rarely responded to the second bevacizumab–containing chemotherapeutic regimen. In such patients, alternate therapies should be considered.

<< Previous
Phase I trial of temozolomide plus O6-benzylguanine 5-day regimen...

Next >>
Sleep-Wake Disturbances in Patients with Advanced Cancer and...